The cardiometabolic benefits of okra-based treatment in prediabetes and diabetes: a systematic review and meta-analysis of randomized controlled trials.
- 2024-12-12
- Systematic Review
- Frontiers in nutrition 11
- Hossein Bahari
- Mostafa Shahraki Jazinaki
- Iman Rahnama
- Ladan Aghakhani
- Mohammad Reza Amini
- Mahsa Malekahmadi
- PubMed: 39726865
- DOI: 10.3389/fnut.2024.1454286
- High evidence
- Clinical
hemoglobin A1C (HbA1c) (WMD: -0.46 mg/dL; (95% CI: -0.79 to -0.13); p = 0.005)
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- ≤3,000 mg/day